Investigator-initiated Trials have struggled post-pandemic with enrollment rates consistently falling short by 25%, while trial sites have lost 50% of their clinical trial staff opting for higher-paying jobs. IITs can benefit greatly by implementing AI-powered unified platform technologies that automate research workflows and data management. They can leverage world-class trial management software, like those used in industry-sponsored trials, but at affordable prices. IITs can take advantage of decentralized tools such as remote video, e-consent, or capturing patient-reported outcomes data remotely through mobile-friendly apps and televisits.

DocWire News spoke with Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics, about Jeeva's recently launched “protocol-to-publication” solution based on the Jeeva™ eClinical Cloud, a specialized, all-in-one SaaS platform that facilitates IIT hybrid or decentralized clinical trials accessible via any mobile browser-enabled device.

свернуть